中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
4期
100-101
,共2页
二甲双胍%胰岛素泵%血糖波动%新诊断乙型糖尿病
二甲雙胍%胰島素泵%血糖波動%新診斷乙型糖尿病
이갑쌍고%이도소빙%혈당파동%신진단을형당뇨병
Metformin%Insulin pump%Blood glucose fluctuations%A new diagnosis of hepatitis b diabetes
目的：观察二甲双胍联合胰岛素泵治对新诊断之型糖尿病血糖波动的影响。方法28例新诊断乙型糖尿病患者按随机数字表分为单纯胰岛素泵治疗组（CSI1组）与二甲双胍联合胰岛素泵治疗组（CSII 联合组），每组各14例，活化治疗2周。结果 CGMS 结果显示：CSZZ联合组与 CSZZ 组相比，均显著下降（P <0.05）治疗后比较两组 A 胰岛素，CSII 联合组均偏低（P <0.05）。结论针对糖尿病患者，实施CSII 诊断能够帮助患者血糖指标恢复正常范围区间，减少胰岛素用量，减轻体重，缩短血糖盗版天数等优势。
目的：觀察二甲雙胍聯閤胰島素泵治對新診斷之型糖尿病血糖波動的影響。方法28例新診斷乙型糖尿病患者按隨機數字錶分為單純胰島素泵治療組（CSI1組）與二甲雙胍聯閤胰島素泵治療組（CSII 聯閤組），每組各14例，活化治療2週。結果 CGMS 結果顯示：CSZZ聯閤組與 CSZZ 組相比，均顯著下降（P <0.05）治療後比較兩組 A 胰島素，CSII 聯閤組均偏低（P <0.05）。結論針對糖尿病患者，實施CSII 診斷能夠幫助患者血糖指標恢複正常範圍區間，減少胰島素用量，減輕體重，縮短血糖盜版天數等優勢。
목적：관찰이갑쌍고연합이도소빙치대신진단지형당뇨병혈당파동적영향。방법28례신진단을형당뇨병환자안수궤수자표분위단순이도소빙치료조（CSI1조）여이갑쌍고연합이도소빙치료조（CSII 연합조），매조각14례，활화치료2주。결과 CGMS 결과현시：CSZZ연합조여 CSZZ 조상비，균현저하강（P <0.05）치료후비교량조 A 이도소，CSII 연합조균편저（P <0.05）。결론침대당뇨병환자，실시CSII 진단능구방조환자혈당지표회복정상범위구간，감소이도소용량，감경체중，축단혈당도판천수등우세。
Objective To observe the pil combined insulin pump treatment of newly diagnosed diabetes blood sugar fluctuations. Methods 28 cases of hepatitis b patients with diabetes are diagnosed according to random number table is divided into pure insulin pump therapy group (group CSI1) with metformin in combination with insulin pump treatment group (CSII group), 14 cases in each group, activating treatment for 2 weeks. Results Showed that CGMS CSZZ joint group compared with CSZZ group were significantly decreased (P < 0.05) after treatment compared two groups of insulin, A joint CSII group were lower (P < 0.05). Conclusion Metformin is new in the diagnosis of hepatitis b patients with diabetes with insulin pump therapy compared with pure intensively treated with insulin pump, to improve blood sugar fluctuation, reduce the dosage of insulin, weight loss, shorten the advantages of the blood sugar number of piracy.
